Vasundhara Rasayans Limited

BSE:538634 Stock Report

Market Cap: ₹897.7m

Vasundhara Rasayans Past Earnings Performance

Past criteria checks 3/6

Vasundhara Rasayans has been growing earnings at an average annual rate of 26.4%, while the Pharmaceuticals industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 15.5% per year. Vasundhara Rasayans's return on equity is 18.3%, and it has net margins of 15.8%.

Key information

26.4%

Earnings growth rate

26.4%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate15.5%
Return on equity18.3%
Net Margin15.8%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Vasundhara Rasayans makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:538634 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2437059330
31 Dec 2335842400
30 Sep 2335745380
30 Jun 2336460370
31 Mar 2337956360
31 Dec 2237066140
30 Sep 2235453220
30 Jun 2229513260
31 Mar 2226822300
31 Dec 2123811410
30 Sep 2123217490
30 Jun 2125838400
31 Mar 2122729410
31 Dec 2021734440
30 Sep 2021635350
30 Jun 2020329350
31 Mar 2021330440
31 Dec 1921414420
30 Sep 192007420
30 Jun 1919710340
31 Mar 1919815410
31 Dec 1819113290
30 Sep 1823119350
30 Jun 1817473290
31 Mar 1816665280
31 Mar 171545330
31 Mar 161532220
31 Mar 151856240
31 Dec 141896230
30 Sep 141918230
30 Jun 1420219220
31 Mar 1420914360
31 Dec 1320916230
30 Sep 1321019230

Quality Earnings: 538634 has high quality earnings.

Growing Profit Margin: 538634's current net profit margins (15.8%) are higher than last year (14.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 538634's earnings have grown significantly by 26.4% per year over the past 5 years.

Accelerating Growth: 538634's earnings growth over the past year (4.8%) is below its 5-year average (26.4% per year).

Earnings vs Industry: 538634 earnings growth over the past year (4.8%) did not outperform the Pharmaceuticals industry 18%.


Return on Equity

High ROE: 538634's Return on Equity (18.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.